- £6.03bn
- £6.06bn
- £500.20m
- 93
- 13
- 50
- 50
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 355 | 369 | 263 | 433 | 500 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 103 | 110 | 102 | 129 | 204 |
Operating Profit | 252 | 259 | 161 | 304 | 297 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 242 | 252 | 157 | 301 | 294 |
Provision for Income Taxes | |||||
Net Income After Taxes | 198 | 205 | 128 | 245 | 234 |
Net Income Before Extraordinary Items | |||||
Net Income | 198 | 205 | 128 | 245 | 234 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 198 | 205 | 128 | 245 | 234 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.202 | 0.22 | 0.132 | 0.256 | 0.233 |
Dividends per Share |